首页 > 最新文献

Schizophrenia (Heidelberg, Germany)最新文献

英文 中文
Associations between second-generation antipsychotics and metabolic outcomes in patients with schizophrenia and metabolic abnormalities. 第二代抗精神病药物与精神分裂症患者代谢结局和代谢异常之间的关系。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2026-01-03 DOI: 10.1038/s41537-025-00718-7
Zhengluan Liao, Yaguan Zhou, Junjie Lin, Suhong Ye, Haihang Yu, Xilong Jin, Lixiu Wei, Guidong Zhu, Zhiyong Lan, Kedeng Fu, Tiantian Zu, Li Ni, Yingying Dong, Heqiu Wang, Yong Zhou, Wei Lv, Juan Huang, Hongfei Wang, Xueming Xu, Xiao Qian, Wanzhen Wu, Liying Liu, Huabin Liu, HuanPing Zhan, Yanbo Chen, Zhilian Pi, Minghua Xie, Xiaolin Xu, Enyan Yu

Second-generation antipsychotics (SGAs) were found to have varying metabolic side-effects for patients with schizophrenia, while no studies have examined the associations between adding or switching low-risk SGAs and metabolic outcomes. This real-world observational study aimed to examine the association of adding or switching to low-risk SGAs with metabolic syndrome and metabolic abnormalities for patients with schizophrenia from 25 healthcare organizations across Zhejiang Province, China. Participants were dichotomized into the low-risk SGAs group and the high/intermediate SGAs group according to whether adding or switching to low-risk SGAs. A 1:1 propensity score matching (PSM) using a nearest-neighbor method was conducted to balance the baseline characteristics between groups. The mean [standard deviation (SD)] age of included patients was 50.0 (12.4) years, and 288 (37.7%) were women. The PSM yielded 223 matched pairs, with no between-group differences in baseline characteristics. Compared to the high/intermediate SGAs group, the low-risk SGAs group showed consistent decreases in the proportion of participants with metabolic syndrome [e.g., at 6 months: risk differences = 19.28%, 95% confidence interval (CI) = -28.19% to -10.38%; odds ratio = 0.47, 95% CI = 0.30 to 0.72] and the number of metabolic abnormalities [e.g., at 6 months: mean difference (MD) = -0.52, 95% CI = -0.75 to -0.29; relative risk = 0.79, 95% CI = 0.71 to 0.87]. The low-risk SGAs group presented significant improvement in metabolic parameters, including lower levels of weight, glucose and triglyceride (e.g., for triglycerise, (MD = -0.41 mmol/L, 95% CI = -0.61 to -0.21 mmol/L at 6 months), compared to the high/intermediate risk SGAs group. These assocaitions were more pronounced in those with no comorbid physical conditions, lower BMI, shorter duration and reporting smoking or drinking. Adding or switching to low-risk antipsychotics was associated with a decrease in metabolic outcomes, which can be considered as an appropriate secondary prevention strategy for patients with both schizophrenia and metabolic abnormalities.

第二代抗精神病药物(SGAs)被发现对精神分裂症患者有不同的代谢副作用,而没有研究检查添加或切换低风险SGAs与代谢结果之间的关系。这项现实世界的观察性研究旨在检查来自中国浙江省25家医疗机构的精神分裂症患者添加或切换到低风险SGAs与代谢综合征和代谢异常的关系。根据是否添加或切换到低风险SGAs,将参与者分为低风险SGAs组和高/中级SGAs组。采用最近邻法进行1:1倾向评分匹配(PSM),以平衡各组之间的基线特征。纳入患者的平均[标准差(SD)]年龄为50.0(12.4)岁,女性288例(37.7%)。PSM产生223对配对,组间基线特征无差异。与高/中级SGAs组相比,低风险SGAs组代谢综合征患者比例持续下降[例如,在6个月时:风险差异= 19.28%,95%置信区间(CI) = -28.19%至-10.38%;优势比= 0.47,95% CI = 0.30 ~ 0.72]和代谢异常的数量[例如,在6个月时:平均差异(MD) = -0.52, 95% CI = -0.75 ~ -0.29;相对危险度= 0.79,95% CI = 0.71 ~ 0.87]。与高/中风险SGAs组相比,低风险SGAs组在代谢参数方面有显著改善,包括较低的体重、葡萄糖和甘油三酯水平(例如,甘油三酯,6个月时MD = -0.41 mmol/L, 95% CI = -0.61至-0.21 mmol/L)。这些关联在那些没有合并症的身体状况、较低的BMI、较短的持续时间和报告吸烟或饮酒的人群中更为明显。添加或切换到低风险抗精神病药物与代谢结果的降低有关,这可以被认为是精神分裂症和代谢异常患者的适当二级预防策略。
{"title":"Associations between second-generation antipsychotics and metabolic outcomes in patients with schizophrenia and metabolic abnormalities.","authors":"Zhengluan Liao, Yaguan Zhou, Junjie Lin, Suhong Ye, Haihang Yu, Xilong Jin, Lixiu Wei, Guidong Zhu, Zhiyong Lan, Kedeng Fu, Tiantian Zu, Li Ni, Yingying Dong, Heqiu Wang, Yong Zhou, Wei Lv, Juan Huang, Hongfei Wang, Xueming Xu, Xiao Qian, Wanzhen Wu, Liying Liu, Huabin Liu, HuanPing Zhan, Yanbo Chen, Zhilian Pi, Minghua Xie, Xiaolin Xu, Enyan Yu","doi":"10.1038/s41537-025-00718-7","DOIUrl":"10.1038/s41537-025-00718-7","url":null,"abstract":"<p><p>Second-generation antipsychotics (SGAs) were found to have varying metabolic side-effects for patients with schizophrenia, while no studies have examined the associations between adding or switching low-risk SGAs and metabolic outcomes. This real-world observational study aimed to examine the association of adding or switching to low-risk SGAs with metabolic syndrome and metabolic abnormalities for patients with schizophrenia from 25 healthcare organizations across Zhejiang Province, China. Participants were dichotomized into the low-risk SGAs group and the high/intermediate SGAs group according to whether adding or switching to low-risk SGAs. A 1:1 propensity score matching (PSM) using a nearest-neighbor method was conducted to balance the baseline characteristics between groups. The mean [standard deviation (SD)] age of included patients was 50.0 (12.4) years, and 288 (37.7%) were women. The PSM yielded 223 matched pairs, with no between-group differences in baseline characteristics. Compared to the high/intermediate SGAs group, the low-risk SGAs group showed consistent decreases in the proportion of participants with metabolic syndrome [e.g., at 6 months: risk differences = 19.28%, 95% confidence interval (CI) = -28.19% to -10.38%; odds ratio = 0.47, 95% CI = 0.30 to 0.72] and the number of metabolic abnormalities [e.g., at 6 months: mean difference (MD) = -0.52, 95% CI = -0.75 to -0.29; relative risk = 0.79, 95% CI = 0.71 to 0.87]. The low-risk SGAs group presented significant improvement in metabolic parameters, including lower levels of weight, glucose and triglyceride (e.g., for triglycerise, (MD = -0.41 mmol/L, 95% CI = -0.61 to -0.21 mmol/L at 6 months), compared to the high/intermediate risk SGAs group. These assocaitions were more pronounced in those with no comorbid physical conditions, lower BMI, shorter duration and reporting smoking or drinking. Adding or switching to low-risk antipsychotics was associated with a decrease in metabolic outcomes, which can be considered as an appropriate secondary prevention strategy for patients with both schizophrenia and metabolic abnormalities.</p>","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":" ","pages":"14"},"PeriodicalIF":4.1,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12868826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145897186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neurobiological illness models of schizophrenia and stigma reduction: has that ship sailed? 精神分裂症的神经生物学疾病模型和减少病耻感:船开了吗?
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-31 DOI: 10.1038/s41537-025-00717-8
Philipp Sterzer, Nicolai Rohner, Christian Huber

Stigma substantially contributes to the burden of psychotic disorders such as schizophrenia. Previous attempts to reduce stigma based on neurobiological illness models were unsuccessful. In this Perspective article, we argue that these models may have failed to reduce stigma in schizophrenia because of their lack of explanatory power and their connotations of biological otherness and determinism. We suggest that recent developments in the realm of computational psychiatry may help to remedy this situation. In particular, we discuss the potential of predictive processing, a highly influential computational framework of brain function, to reduce the stigma associated with schizophrenia. We argue that predictive processing accounts may do so by bridging the explanatory gap between biology and psychotic experiences within a normative theory of brain function, thus offering a normalizing perspective on the neural underpinnings of schizophrenia. This may facilitate not only a better understanding of psychotic experiences but also counteract connotations of biological determinism and foster belief in change. Viewing schizophrenia through the lens of predictive processing may thus pave the way for the integration of neurobiologically grounded models into the communication with patients, their relatives, and the public, which have the potential to reduce stigma.

耻辱感在很大程度上加重了精神分裂症等精神障碍的负担。以前基于神经生物学疾病模型减少病耻感的尝试都不成功。在这篇Perspective文章中,我们认为这些模型可能未能减少精神分裂症的耻辱感,因为它们缺乏解释力,并且它们的生物学差异性和决定论的内涵。我们认为,计算精神病学领域的最新发展可能有助于纠正这种情况。特别是,我们讨论了预测处理的潜力,一个极具影响力的脑功能计算框架,以减少与精神分裂症相关的耻辱。我们认为,通过在脑功能规范理论中弥合生物学和精神病经历之间的解释差距,预测处理可以做到这一点,从而为精神分裂症的神经基础提供了一个正常化的视角。这可能不仅有助于更好地理解精神病的经历,而且还抵消了生物决定论的内涵,培养了对变化的信念。因此,通过预测处理的视角来看待精神分裂症,可能为将基于神经生物学的模型整合到与患者、其亲属和公众的交流中铺平道路,这有可能减少耻辱感。
{"title":"Neurobiological illness models of schizophrenia and stigma reduction: has that ship sailed?","authors":"Philipp Sterzer, Nicolai Rohner, Christian Huber","doi":"10.1038/s41537-025-00717-8","DOIUrl":"10.1038/s41537-025-00717-8","url":null,"abstract":"<p><p>Stigma substantially contributes to the burden of psychotic disorders such as schizophrenia. Previous attempts to reduce stigma based on neurobiological illness models were unsuccessful. In this Perspective article, we argue that these models may have failed to reduce stigma in schizophrenia because of their lack of explanatory power and their connotations of biological otherness and determinism. We suggest that recent developments in the realm of computational psychiatry may help to remedy this situation. In particular, we discuss the potential of predictive processing, a highly influential computational framework of brain function, to reduce the stigma associated with schizophrenia. We argue that predictive processing accounts may do so by bridging the explanatory gap between biology and psychotic experiences within a normative theory of brain function, thus offering a normalizing perspective on the neural underpinnings of schizophrenia. This may facilitate not only a better understanding of psychotic experiences but also counteract connotations of biological determinism and foster belief in change. Viewing schizophrenia through the lens of predictive processing may thus pave the way for the integration of neurobiologically grounded models into the communication with patients, their relatives, and the public, which have the potential to reduce stigma.</p>","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":" ","pages":"13"},"PeriodicalIF":4.1,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12868759/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145879581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Polygenic risk for schizophrenia is associated with white matter microstructure, cognitive and mental health. 精神分裂症的多基因风险与白质微观结构、认知和心理健康有关。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-30 DOI: 10.1038/s41537-025-00714-x
Qian Qian, Guoshu Zhao, Nannan Zhang, Shaoying Wang, Jinghan Sun, Feng Liu, Jiayuan Xu, Chunshui Yu

Schizophrenia is highly heritable, and polygenic risk score for schizophrenia (PRSSCZ) has been associated with brain and behavior in healthy populations. However, the full associations of PRSSCZ with brain white matter microstructure and cognitive and mental health outcomes, the potential effects of sex and areal deprivation on these associations, and the mediation of white matter microstructure for the associations between PRSSCZ and behavioral outcomes remain largely unknown. In up to 300,000 participants from the UK Biobank, we investigated the associations of PRSSCZ with eight white matter microstructure metrics of 48 tracts and 14 cognitive and mental health phenotypes, and we further tested the moderation of sex and index of multiple deprivation (IMD) on these associations and the mediation of brain white matter phenotypes for the associations between PRSSCZ and behavioral outcomes. We found that higher PRSSCZ was associated with decreased white matter integrity in 26 tracts, such as cingulum, corona radiata, and fornix. We also found that higher PRSSCZ was associated with poorer mental health and worse cognitive performance. These associations were not significantly moderated by sex and IMD. Causal mediation analyses revealed that these adverse effects of PRSSCZ on cognitive and mental health outcomes were partially mediated by brain white matter phenotypes. These results indicate that genetic risk for schizophrenia affects the integrity of white matter tracts, which may account for its adverse effects on cognitive and mental health outcomes.

精神分裂症具有高度遗传性,在健康人群中,精神分裂症多基因风险评分(PRSSCZ)与大脑和行为相关。然而,PRSSCZ与脑白质微观结构、认知和心理健康结果之间的完全关联、性别和区域剥夺对这些关联的潜在影响,以及PRSSCZ与行为结果之间的白质微观结构的中介作用在很大程度上仍是未知的。在英国生物银行(UK Biobank)多达30万名参与者中,我们研究了PRSSCZ与48个脑区8个白质微观结构指标和14种认知和心理健康表型的关联,并进一步测试了性别和多重剥夺指数(IMD)对这些关联的调节作用,以及脑白质表型对PRSSCZ与行为结果之间关联的中介作用。我们发现,较高的PRSSCZ与26个脑束的白质完整性下降有关,如扣带、辐射冠和穹窿。我们还发现,较高的PRSSCZ与较差的心理健康和较差的认知表现有关。这些关联不受性别和IMD的显著调节。因果中介分析显示,PRSSCZ对认知和心理健康结果的不利影响部分由脑白质表型介导。这些结果表明,精神分裂症的遗传风险影响白质束的完整性,这可能解释了其对认知和心理健康结果的不利影响。
{"title":"Polygenic risk for schizophrenia is associated with white matter microstructure, cognitive and mental health.","authors":"Qian Qian, Guoshu Zhao, Nannan Zhang, Shaoying Wang, Jinghan Sun, Feng Liu, Jiayuan Xu, Chunshui Yu","doi":"10.1038/s41537-025-00714-x","DOIUrl":"10.1038/s41537-025-00714-x","url":null,"abstract":"<p><p>Schizophrenia is highly heritable, and polygenic risk score for schizophrenia (PRS<sub>SCZ</sub>) has been associated with brain and behavior in healthy populations. However, the full associations of PRS<sub>SCZ</sub> with brain white matter microstructure and cognitive and mental health outcomes, the potential effects of sex and areal deprivation on these associations, and the mediation of white matter microstructure for the associations between PRS<sub>SCZ</sub> and behavioral outcomes remain largely unknown. In up to 300,000 participants from the UK Biobank, we investigated the associations of PRS<sub>SCZ</sub> with eight white matter microstructure metrics of 48 tracts and 14 cognitive and mental health phenotypes, and we further tested the moderation of sex and index of multiple deprivation (IMD) on these associations and the mediation of brain white matter phenotypes for the associations between PRS<sub>SCZ</sub> and behavioral outcomes. We found that higher PRS<sub>SCZ</sub> was associated with decreased white matter integrity in 26 tracts, such as cingulum, corona radiata, and fornix. We also found that higher PRS<sub>SCZ</sub> was associated with poorer mental health and worse cognitive performance. These associations were not significantly moderated by sex and IMD. Causal mediation analyses revealed that these adverse effects of PRS<sub>SCZ</sub> on cognitive and mental health outcomes were partially mediated by brain white matter phenotypes. These results indicate that genetic risk for schizophrenia affects the integrity of white matter tracts, which may account for its adverse effects on cognitive and mental health outcomes.</p>","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":" ","pages":"12"},"PeriodicalIF":4.1,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12858994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145866190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disrupted rest-task shift of multi-band electroencephalography complexity in patients with schizophrenia. 精神分裂症患者多波段脑电图复杂性的休息-任务转移中断。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-22 DOI: 10.1038/s41537-025-00713-y
Shunsuke Tamura, Tsuyoshi Iwasaki, Osamu Ichikawa, Kantaro Nishigori, Yoshihiro Iwamura, Takako Fujimoto, Tatsuhiro Tamada, Hidetaka Nagata, Yoji Hirano

Brain activity undergoes intrinsic fluctuations with complexities specific to both the resting state and the task state. However, in patients with schizophrenia (SZ), where the boundary between internal and external realms is blurred, optimal modulation of these complexities between rest and stimulus phases is likely disrupted. Here, we present a frequency-dependent rest-task shift in electroencephalography (EEG) complexity in normal controls (NCs) and the associated abnormal patterns in patients with SZ. Specifically, we examined EEG complexity in different frequency bands, quantified by multiscale entropy (MSE), during the resting state and a 40 Hz auditory steady-state response (ASSR) task in 77 normal controls (NCs) and 103 patients with SZ. We compared the ASSR/resting MSE ratio between the NC and SZ groups. In the NC group, transitioning from the resting state to the ASSR state caused increased alpha-band entropy and decreased gamma-band entropy, whereas no such shifts were observed in patients with SZ. This study suggests that in NCs, alpha-band oscillatory complexity, which influences cortical response properties, increases during the transition from intrinsic to extrinsic information processing, while gamma-band oscillatory complexity decreases, likely due to concentration on auditory processing of a temporal enriching stimulation with high salience. Patients with SZ, which are marked by impaired neural synchrony, lacked the NCs' pronounced changes in neural complexity across frequency bands. This indicates that in patients with SZ, disruptions in the spontaneous activity that shapes the internal mental state may alter the properties of cortical responses and entrainment to external stimuli.

大脑活动在静息状态和任务状态下都会经历内在的复杂波动。然而,在精神分裂症患者(SZ)中,内部和外部领域之间的界限模糊,休息和刺激阶段之间这些复杂性的最佳调节可能会中断。在这里,我们研究了正常对照(nc)的脑电图(EEG)复杂性的频率依赖的休息-任务转移,以及SZ患者的相关异常模式。具体来说,我们研究了77名正常对照(nc)和103名SZ患者在静息状态和40 Hz听觉稳态反应(ASSR)任务期间不同频带的EEG复杂性,并用多尺度熵(MSE)量化。我们比较了NC组和SZ组的ASSR/静息MSE比。在NC组中,从静息状态过渡到ASSR状态导致α带熵增加和γ带熵减少,而在SZ患者中没有观察到这种变化。该研究表明,在神经网络中,影响皮层反应特性的α波段振荡复杂性在从内在信息加工到外在信息加工的转变过程中增加,而γ波段振荡复杂性则减少,这可能是由于集中在具有高度显著性的时间丰富刺激的听觉加工上。SZ患者以神经同步性受损为特征,缺乏nc在各频段神经复杂性的显著变化。这表明,在SZ患者中,形成内部精神状态的自发活动的中断可能会改变皮层对外部刺激的反应和携带的性质。
{"title":"Disrupted rest-task shift of multi-band electroencephalography complexity in patients with schizophrenia.","authors":"Shunsuke Tamura, Tsuyoshi Iwasaki, Osamu Ichikawa, Kantaro Nishigori, Yoshihiro Iwamura, Takako Fujimoto, Tatsuhiro Tamada, Hidetaka Nagata, Yoji Hirano","doi":"10.1038/s41537-025-00713-y","DOIUrl":"10.1038/s41537-025-00713-y","url":null,"abstract":"<p><p>Brain activity undergoes intrinsic fluctuations with complexities specific to both the resting state and the task state. However, in patients with schizophrenia (SZ), where the boundary between internal and external realms is blurred, optimal modulation of these complexities between rest and stimulus phases is likely disrupted. Here, we present a frequency-dependent rest-task shift in electroencephalography (EEG) complexity in normal controls (NCs) and the associated abnormal patterns in patients with SZ. Specifically, we examined EEG complexity in different frequency bands, quantified by multiscale entropy (MSE), during the resting state and a 40 Hz auditory steady-state response (ASSR) task in 77 normal controls (NCs) and 103 patients with SZ. We compared the ASSR/resting MSE ratio between the NC and SZ groups. In the NC group, transitioning from the resting state to the ASSR state caused increased alpha-band entropy and decreased gamma-band entropy, whereas no such shifts were observed in patients with SZ. This study suggests that in NCs, alpha-band oscillatory complexity, which influences cortical response properties, increases during the transition from intrinsic to extrinsic information processing, while gamma-band oscillatory complexity decreases, likely due to concentration on auditory processing of a temporal enriching stimulation with high salience. Patients with SZ, which are marked by impaired neural synchrony, lacked the NCs' pronounced changes in neural complexity across frequency bands. This indicates that in patients with SZ, disruptions in the spontaneous activity that shapes the internal mental state may alter the properties of cortical responses and entrainment to external stimuli.</p>","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":" ","pages":"156"},"PeriodicalIF":4.1,"publicationDate":"2025-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12749793/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145812248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online tools. 授权临床医生和患者减少精神分裂症的抗精神病药物剂量:在线工具的作用。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-17 DOI: 10.1038/s41537-025-00699-7
Stefan Leucht, Alessandro Rodolico
{"title":"Empowering clinicians and patients in antipsychotic dose reduction for schizophrenia: the role of online tools.","authors":"Stefan Leucht, Alessandro Rodolico","doi":"10.1038/s41537-025-00699-7","DOIUrl":"10.1038/s41537-025-00699-7","url":null,"abstract":"","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":"11 1","pages":"153"},"PeriodicalIF":4.1,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antipsychotic treatment in schizophrenia: balancing relapse prevention and functional recovery. 精神分裂症的抗精神病药物治疗:平衡复发预防和功能恢复。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-17 DOI: 10.1038/s41537-025-00697-9
Jan P A M Bogers
{"title":"Antipsychotic treatment in schizophrenia: balancing relapse prevention and functional recovery.","authors":"Jan P A M Bogers","doi":"10.1038/s41537-025-00697-9","DOIUrl":"10.1038/s41537-025-00697-9","url":null,"abstract":"","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":"11 1","pages":"154"},"PeriodicalIF":4.1,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712057/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helping people to discontinue antipsychotics: if, when and how. 帮助人们停用抗精神病药物:如果、何时以及如何停用。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-17 DOI: 10.1038/s41537-025-00695-x
Joanna Moncrieff, Mark Abie Horowitz

The default position in the treatment of psychotic conditions is that lifelong treatment is required after multiple episodes, with some portion of patients able to stop after a single episode. However, there are reasons to question this consensus, including that not everyone who stops antipsychotics relapses, the protective effects of antipsychotics may have been exaggerated due to the possibility that withdrawal itself is associated with adverse effects, including relapse, there is little evidence that antipsychotics target a pathological mechanism and their adverse effects may outweigh their benefits for some users. Recent pragmatic trials that employ a gradual reduction strategy give mixed results. They highlight that relapse is still a potential risk, but there may be gains in terms of social functioning in the long-term. There are no consistent factors that enable identification of people who might be able to discontinue antipsychotics more successfully, suggesting this option should be more widely offered. A gradual, hyperbolic approach to tapering has been proposed to reduce the adverse effects of withdrawal and relapse on stopping-approximated, for example, by reductions of 5-10% of the most recent dose every month. Patients should be supported to make decisions about long-term antipsychotic treatment based on weighing up the pros and cons of antipsychotic effects, in the light of the evidence base and the individual's priorities. Given that increasing duration of treatment is likely to increase the risk of withdrawal on stopping, long-term antipsychotic treatment should be minimized where possible.

精神疾病治疗的默认立场是,多次发作后需要终身治疗,部分患者在一次发作后可以停止治疗。然而,有理由质疑这一共识,包括并不是每个停止抗精神病药物的人都会复发,抗精神病药物的保护作用可能被夸大了,因为戒断本身可能与包括复发在内的不良反应有关,几乎没有证据表明抗精神病药物针对病理机制,而且对一些使用者来说,它们的副作用可能超过它们的益处。最近采用逐步减少策略的务实试验结果好坏参半。他们强调,复发仍然是一个潜在的风险,但从长期来看,在社会功能方面可能会有所收获。目前还没有一致的因素能够确定哪些人能够更成功地停用抗精神病药物,这表明应该更广泛地提供这种选择。已经提出了一种渐进的、双曲线的方法来减少停药和停药后复发的不良影响,例如,每月减少最近一次剂量的5-10%。应支持患者在权衡抗精神病药物作用的利弊的基础上,根据证据基础和个人的优先考虑,做出长期抗精神病药物治疗的决定。鉴于延长治疗时间可能增加停药后停药的风险,应尽可能减少长期抗精神病药物治疗。
{"title":"Helping people to discontinue antipsychotics: if, when and how.","authors":"Joanna Moncrieff, Mark Abie Horowitz","doi":"10.1038/s41537-025-00695-x","DOIUrl":"10.1038/s41537-025-00695-x","url":null,"abstract":"<p><p>The default position in the treatment of psychotic conditions is that lifelong treatment is required after multiple episodes, with some portion of patients able to stop after a single episode. However, there are reasons to question this consensus, including that not everyone who stops antipsychotics relapses, the protective effects of antipsychotics may have been exaggerated due to the possibility that withdrawal itself is associated with adverse effects, including relapse, there is little evidence that antipsychotics target a pathological mechanism and their adverse effects may outweigh their benefits for some users. Recent pragmatic trials that employ a gradual reduction strategy give mixed results. They highlight that relapse is still a potential risk, but there may be gains in terms of social functioning in the long-term. There are no consistent factors that enable identification of people who might be able to discontinue antipsychotics more successfully, suggesting this option should be more widely offered. A gradual, hyperbolic approach to tapering has been proposed to reduce the adverse effects of withdrawal and relapse on stopping-approximated, for example, by reductions of 5-10% of the most recent dose every month. Patients should be supported to make decisions about long-term antipsychotic treatment based on weighing up the pros and cons of antipsychotic effects, in the light of the evidence base and the individual's priorities. Given that increasing duration of treatment is likely to increase the risk of withdrawal on stopping, long-term antipsychotic treatment should be minimized where possible.</p>","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":"11 1","pages":"149"},"PeriodicalIF":4.1,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12711913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom? 首发和多期精神障碍或精神分裂症患者停用抗精神病药物的益处和风险:为什么、何时、如何以及对谁停用?
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-17 DOI: 10.1038/s41537-025-00700-3
Christoph U Correll, Jose M Rubio, John M Kane
{"title":"Benefits and risks of antipsychotic discontinuation in people with first and multi-episode psychotic disorders or with schizophrenia: why, when, how and in whom?","authors":"Christoph U Correll, Jose M Rubio, John M Kane","doi":"10.1038/s41537-025-00700-3","DOIUrl":"10.1038/s41537-025-00700-3","url":null,"abstract":"","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":"11 1","pages":"151"},"PeriodicalIF":4.1,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712082/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Three dimensions of speech coherence in people with early psychosis and their family members. 早期精神病患者及其家庭成员言语连贯的三个维度。
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-17 DOI: 10.1038/s41537-025-00703-0
Derya Çokal, Abdulrahman Aloraini, Claudio Flores Palominos, Cemal Demirlek, Burcu Verim, Berna Yalınçetin, Emre Bora, Wolfram Hinzen

Fundamental to coherence in discourse is referential structure - identifying entities through noun phrases (NPs, e.g. a man; that large cat) and tracking them in discourse. But coherence is also mediated by conceptual-semantic structure, as tracked through semantic similarity relations between words, and by predictability ("perplexity"). Alterations in speech coherence have long been noted in schizophrenia spectrum disorders (SSD) along all three of these dimensions. These are likely connected, but have largely been studied in isolation. This study targeted them together, in Turkish-speaking people with a first episode of psychosis (FEP, n = 53), youths at ultra-high risk (UHR, n = 64) of SSD, people with a family history of psychosis (FHP, N = 39), and 34 neurotypical controls (NC). In FEP, we confirmed a pattern previously attested in chronic SSD, of fewer definite NPs (e.g., this bald man), more "bare" NPs-i.e., lacking functional elements such as this/a -, and an unexpected random distribution of indefinite NPs; moreover, referential anomalies (unclarities of reference) were more prevalent in all groups relative to NC. FEP and UHR also showed higher word-to-word semantic similarity, and FEP larger image-to-text bimodal semantic distance, mirroring a pattern previously attested in English. NP-related variables related to both semantic similarity and perplexity, with crucially different correlational patterns seen for definite vs. indefinite NPs. Together, these results substantiate crosslinguistic evidence of a referential disturbance in early psychosis, partially extending to the extended schizophrenia phenotype, while additionally supporting that referential structure is closely integrated with conceptual semantics and the probabilistic structure of speech.

语篇连贯的基础是指称结构——通过名词短语(例如,一个人;那只大猫)识别实体,并在语篇中追踪它们。但连贯性也受到概念语义结构(通过单词之间的语义相似关系进行追踪)和可预测性(“困惑”)的调节。在精神分裂症谱系障碍(SSD)中,语言连贯性的改变在这三个方面都很早就被注意到。这些可能是有联系的,但在很大程度上是单独研究的。本研究的目标人群为首发精神病的土耳其语人群(FEP, n = 53)、SSD超高风险青年(UHR, n = 64)、有精神病家族史的人群(FHP, n = 39)和34名神经正常对照(NC)。在FEP中,我们证实了以前在慢性SSD中证实的模式,明确的NPs较少(例如,这个秃顶的男人),更多的“裸”NPs-即:,缺乏this/a -等功能元素,以及不确定NPs的意外随机分布;此外,参考异常(参考不清)在所有组中相对于NC更为普遍。FEP和UHR也显示出更高的词与词之间的语义相似性,FEP显示出更大的图像与文本的双峰语义距离,这反映了之前在英语中证实的模式。与np相关的变量与语义相似度和困惑度相关,在确定的np和不确定的np中可以看到截然不同的相关模式。总之,这些结果证实了早期精神病中存在参照障碍的跨语言证据,部分延伸到扩展的精神分裂症表型,同时额外支持参照结构与概念语义和言语概率结构密切相关。
{"title":"Three dimensions of speech coherence in people with early psychosis and their family members.","authors":"Derya Çokal, Abdulrahman Aloraini, Claudio Flores Palominos, Cemal Demirlek, Burcu Verim, Berna Yalınçetin, Emre Bora, Wolfram Hinzen","doi":"10.1038/s41537-025-00703-0","DOIUrl":"10.1038/s41537-025-00703-0","url":null,"abstract":"<p><p>Fundamental to coherence in discourse is referential structure - identifying entities through noun phrases (NPs, e.g. a man; that large cat) and tracking them in discourse. But coherence is also mediated by conceptual-semantic structure, as tracked through semantic similarity relations between words, and by predictability (\"perplexity\"). Alterations in speech coherence have long been noted in schizophrenia spectrum disorders (SSD) along all three of these dimensions. These are likely connected, but have largely been studied in isolation. This study targeted them together, in Turkish-speaking people with a first episode of psychosis (FEP, n = 53), youths at ultra-high risk (UHR, n = 64) of SSD, people with a family history of psychosis (FHP, N = 39), and 34 neurotypical controls (NC). In FEP, we confirmed a pattern previously attested in chronic SSD, of fewer definite NPs (e.g., this bald man), more \"bare\" NPs-i.e., lacking functional elements such as this/a -, and an unexpected random distribution of indefinite NPs; moreover, referential anomalies (unclarities of reference) were more prevalent in all groups relative to NC. FEP and UHR also showed higher word-to-word semantic similarity, and FEP larger image-to-text bimodal semantic distance, mirroring a pattern previously attested in English. NP-related variables related to both semantic similarity and perplexity, with crucially different correlational patterns seen for definite vs. indefinite NPs. Together, these results substantiate crosslinguistic evidence of a referential disturbance in early psychosis, partially extending to the extended schizophrenia phenotype, while additionally supporting that referential structure is closely integrated with conceptual semantics and the probabilistic structure of speech.</p>","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":" ","pages":"2"},"PeriodicalIF":4.1,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12775532/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antipsychotic discontinuation in schizophrenia: rational or reckless? 精神分裂症患者停用抗精神病药物:理性还是鲁莽?
IF 4.1 Q2 PSYCHIATRY Pub Date : 2025-12-17 DOI: 10.1038/s41537-025-00698-8
Robert B Zipursky, Ofer Agid, Gary Remington
{"title":"Antipsychotic discontinuation in schizophrenia: rational or reckless?","authors":"Robert B Zipursky, Ofer Agid, Gary Remington","doi":"10.1038/s41537-025-00698-8","DOIUrl":"10.1038/s41537-025-00698-8","url":null,"abstract":"","PeriodicalId":74758,"journal":{"name":"Schizophrenia (Heidelberg, Germany)","volume":"11 1","pages":"150"},"PeriodicalIF":4.1,"publicationDate":"2025-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12712088/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145776666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Schizophrenia (Heidelberg, Germany)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1